Producto añadido correctamente al carrito.

discount label
H-STPESANL-OH
Ver en 3D

Biosynth logo

H-STPESANL-OH

Ref. 3D-PP44299

1mg
202,00 €
10mg
234,00 €
100mg
412,00 €
Entrega estimada en Estados Unidos, el Viernes 27 de Diciembre de 2024

Información del producto

Nombre:
H-STPESANL-OH
Sinónimos:
  • NH2-Ser-Thr-Pro-Glu-Ser-Ala-Asn-Leu-OH
Descripción:

Peptide H-STPESANL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-STPESANL-OH include the following: IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of YM Mueller , DH Do, SR Altork , CM Artlett - The Journal of , 2008 - journals.aai.orghttps://journals.aai.org/jimmunol/article/180/1/350/78382 Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia TM Allen , DH O'Connor , P Jing, JL Dzuris, BR Mothe - Nature, 2000 - nature.comhttps://www.nature.com/articles/35030124 Mapping sites of positive selection and amino acid diversification in the HIV genome: an alternative approach to vaccine design? T De Oliveira , M Salemi , M Gordon , AM Vandamme - Genetics, 2004 - academic.oup.comhttps://academic.oup.com/genetics/article-abstract/167/3/1047/6050617 Maintenance or Emergence of Chronic Phase Secondary Cytotoxic T Lymphocyte Responses after Loss of Acute Phase Immunodominant Responses Does Not MS Keckler, VL Hodara , LM Parodi - BioMed Research , 2010 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1155/2010/279391 The Antiviral Efficacy of Simian Immunodeficiency Virus-Specific CD8+ T Cells Is Unrelated to Epitope Specificity and Is Abrogated by Viral Escape JT Loffredo, BJ Burwitz , EG Rakasz - Journal of , 2007 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.01912-06 Engineering RENTA, a DNA prime-MVA boost HIV vaccine tailored for Eastern and Central Africa JP Nkolola, EGT Wee, EJ Im, CP Jewell, N Chen - Gene therapy, 2004 - nature.comhttps://www.nature.com/articles/3302241 Analysis of the immune response and viral evolution during the acute phase of SIV infection H Horton, T Vogel, D O'Connor , L Picker , DI Watkins - Vaccine, 2002 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X02000695 Induction of long-lasting multi-specific CD8+ T cells by a four-component DNA-MVA/HIVA-RENTA candidate HIV-1 vaccine in rhesus macaques EJ Im, JP Nkolola, K di Gleria - European journal of , 2006 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200636482 Compartmentalization of simian immunodeficiency virus replication within secondary lymphoid tissues of rhesus macaques is linked to disease stage and inversely E Connick , JM Folkvord, KT Lind - The Journal of , 2014 - journals.aai.orghttps://journals.aai.org/jimmunol/article/193/11/5613/96601 Compartmentalization of SIV Replication Within Secondary Lymphoid Tissues of Rhesus Macaques is Linked to Disease Stage and Inversely Related to E Connick , JM Folkvord, KT Lind - (Baltimore, Md.: 1950 , 2014 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239212/ Vaccination with CTL epitopes that escape: an alternative approach to HIV vaccine development? D O'Connor , T Allen , DI Watkins - Immunology letters, 2001 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0165247801002681 Simultaneous Positive and Purifying Selection on Overlapping Reading Frames of the tat andvpr Genes of Simian Immunodeficiency Virus AL Hughes, K Westover, J da Silva - Journal of , 2001 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.75.17.7966-7972.2001 Location and dynamics of the immunodominant CD8 T cell response to SIVΔnef immunization and SIVmac251 vaginal challenge AK Sasikala-Appukuttan, HO Kim, NJ Kinzel, JJ Hong - PloS one, 2013 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0081623 The Mucosal Barrier and Anti-Viral Immune Responses can Eliminate Portions of the Viral Population during Transmission and Early Viral Growth AE Golfinos, DD Gellerup, H Schweigert - 2021 - preprints.orghttps://www.preprints.org/manuscript/202105.0206

Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:

Propiedades químicas

MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:

Información de peligrosidad

Número UN:
Cantidad exceptuada (EQ):
Clase:
Frases H:
Frases P:
Prohibido volar:
Información de peligrosidad:
Grupo de empaquetado:
Cantidad limitada (LQ):

Consulta técnica sobre: 3D-PP44299 H-STPESANL-OH

Use el carrito para solicitar presupuestos o pedidos

Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.

* Campos obligatorios
¡Bienvenido a CymitQuimica!Utilizamos cookies para mejorar su visita. No incluimos publicidad.

Consulte nuestra Política de Cookies para obtener más información o ajuste sus preferencias en "Configurar".